Summary of Significant Accounting Policies - Accounts receivable and Concentrations (Details) - item	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Supplier risk
Concentrations
Number of suppliers	2
Total net revenue | Customer risk | One major pharmaceutical distributors
Concentrations
Number of major distributors	3	1
Total net revenue | Customer risk | Customer 1
Concentrations
Concentration risk (as a percentage)		73.00%
Total net revenue | Customer risk | Customer 2
Concentrations
Concentration risk (as a percentage)	35.00%	11.00%
Total net revenue | Customer risk | Customer 3
Concentrations
Concentration risk (as a percentage)	53.00%	12.00%
Total net revenue | Customer risk | Minimum | Customer 1
Concentrations
Concentration risk (as a percentage)	10.00%	10.00%
Total accounts receivable | Customer risk | Customer 1
Concentrations
Concentration risk (as a percentage)		16.00%
Total accounts receivable | Customer risk | Customer 2
Concentrations
Concentration risk (as a percentage)	38.00%	37.00%
Total accounts receivable | Customer risk | Customer 3
Concentrations
Concentration risk (as a percentage)	54.00%	37.00%